TTY Biopharm Company Limited

TPEX:4105 Voorraadrapport

Marktkapitalisatie: NT$18.2b

TTY Biopharm Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

TTY Biopharm has a total shareholder equity of NT$6.5B and total debt of NT$2.4B, which brings its debt-to-equity ratio to 36.9%. Its total assets and total liabilities are NT$10.2B and NT$3.7B respectively. TTY Biopharm's EBIT is NT$1.4B making its interest coverage ratio -25. It has cash and short-term investments of NT$2.8B.

Belangrijke informatie

36.9%

Verhouding schuld/eigen vermogen

NT$2.40b

Schuld

Rente dekkingsratio-25x
ContantNT$2.85b
AandelenNT$6.51b
Totaal verplichtingenNT$3.74b
Totaal activaNT$10.25b

Recente financiële gezondheidsupdates

Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

Apr 02
Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

Dec 15
TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

Recent updates

Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

Apr 02
Here's Why TTY Biopharm (GTSM:4105) Can Manage Its Debt Responsibly

Is There An Opportunity With TTY Biopharm Company Limited's (GTSM:4105) 43% Undervaluation?

Mar 15
Is There An Opportunity With TTY Biopharm Company Limited's (GTSM:4105) 43% Undervaluation?

Are Dividend Investors Making A Mistake With TTY Biopharm Company Limited (GTSM:4105)?

Feb 25
Are Dividend Investors Making A Mistake With TTY Biopharm Company Limited (GTSM:4105)?

TTY Biopharm Company Limited (GTSM:4105) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Feb 07
TTY Biopharm Company Limited (GTSM:4105) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

TTY Biopharm Company Limited (GTSM:4105) Analysts Just Cut Their EPS Forecasts Substantially

Jan 19
TTY Biopharm Company Limited (GTSM:4105) Analysts Just Cut Their EPS Forecasts Substantially

What Type Of Returns Would TTY Biopharm's(GTSM:4105) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Jan 10
What Type Of Returns Would TTY Biopharm's(GTSM:4105) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

Dec 15
TTY Biopharm (GTSM:4105) Has A Pretty Healthy Balance Sheet

How Does TTY Biopharm Company Limited (GTSM:4105) Fare As A Dividend Stock?

Nov 25
How Does TTY Biopharm Company Limited (GTSM:4105) Fare As A Dividend Stock?

Analyse van de financiële positie

Kortlopende schulden: 4105's short term assets (NT$5.5B) exceed its short term liabilities (NT$3.0B).

Langlopende schulden: 4105's short term assets (NT$5.5B) exceed its long term liabilities (NT$756.1M).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 4105 has more cash than its total debt.

Schuld verminderen: 4105's debt to equity ratio has increased from 18% to 36.9% over the past 5 years.

Schuldendekking: 4105's debt is well covered by operating cash flow (45.3%).

Rentedekking: 4105 earns more interest than it pays, so coverage of interest payments is not a concern.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y